Stocktoria

MYRIAD GENETICS INC MYGN

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-06 · LEI

MYRIAD GENETICS INC institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.15,150,806$370.6M16.2%
MILLENNIUM MANAGEMENT LLC6,620,372$37.8M7.08%
D. E. Shaw & Co., Inc.4,582,083$26.2M4.9%
AQR CAPITAL MANAGEMENT LLC2,766,689$15.8M2.96%
CITADEL ADVISORS LLC1,585,984$9.1M1.7%
TWO SIGMA INVESTMENTS, LP1,557,727$8.9M1.67%
Point72 Asset Management, L.P.238,776$1.4M0.26%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.